Thermo Fisher Scientific Acquires nAscent BioSciences
News Jan 29, 2008
The nAscent product lines, which include the PocketTip® pipette tip, will be integrated into Thermo Fisher Scientific’s existing liquid handling consumables business.
PocketTip technology combines nanoliter metering with microliter diluting in a pipette tip for most commercially available liquid handling automated platforms. This product provides scientists with a tool that reagents, consumables and labor traditionally required for primary and secondary screening during drug discovery.
“A key element of our business strategy is to provide our customers with innovative and differentiated products that deliver real workflow solutions for drug discovery,” said Timo Hilden, vice president and general manager of Thermo Fisher Scientific’s liquid handling consumables business. “This acquisition is in line with that product portfolio strategy and also expands Thermo Fisher Scientific’s capabilities in the increasingly important area of nanoliter liquid handling.”
“We are very excited about Thermo Fisher Scientific’s ability to take the PocketTip product line to the next level,” said Dave Stoldt, nAscent’s president and CEO.
“They bring unsurpassed depth in sales and distribution of laboratory consumables, as well as integrated laboratory automation solutions. Our existing customers will continue to receive the quality and benefits they have come to expect, but Thermo Fisher Scientific’s long-standing global leadership in this sector will allow the features and benefits of PocketTip to become available to new customers for new applications.”
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE